Showing results (1891-1900 of 6,517) with videos related to

Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|January 1, 1990
Induction of high-grade anti-tumor immunity by use of a recombinant H-2Kb/avian erythroblastosis virus erbB gene transfectantL N Ding, K Isobe, T Yoshida, et al.
Cancer Immunology, Immunotherapy : CII|June 10, 2011
Myxoma virus combined with rapamycin treatment enhances adoptive T cell therapy for murine melanoma brain tumorsDiana L Thomas, Rosalinda Doty, Vesna Tosic, et al.
Cancer Immunology, Immunotherapy : CII|June 22, 2011
Poly(I:C)-induced tumour cell death leads to DC maturation and Th1 activationEdit Kovalcsik, Katie Lowe, Mike Fischer, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1989
Homogeneous penetration but heterogeneous binding of antibodies to carcinoembryonic antigen in human colon carcinoma HT-29 spheroidsJ Carlsson, E Daniel-Szolgay, G Frykholm, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1989
Induction of cytotoxicity from fresh splenocytes after in vivo administration of cyclophosphamide. Importance of long-term culture with high-dose recombinant interleukin-2R Kim, R Lafreniere, K Borkenhagen, et al.
Cancer Immunology, Immunotherapy : CII|August 8, 2015
Mesenchymal stromal cells inhibit murine syngeneic anti-tumor immune responses by attenuating inflammation and reorganizing the tumor microenvironmentJaime F Modiano, Beth A Lindborg, Ron T McElmurry, et al.
Cancer Immunology, Immunotherapy : CII|November 20, 2015
A randomized pilot trial testing the safety and immunologic effects of a MAGE-A3 protein plus AS15 immunostimulant administered into muscle or into dermal/subcutaneous sitesCraig L Slingluff, Gina R Petroni, Walter C Olson, et al.
Cancer Immunology, Immunotherapy : CII|January 14, 2016
Serum elevation of B lymphocyte stimulator does not increase regulatory B cells in glioblastoma patients undergoing immunotherapyAnirudh Saraswathula, Elizabeth A Reap, Bryan D Choi, et al.
Cancer Immunology, Immunotherapy : CII|January 14, 2016
Identification of the murine H-2D(b) and human HLA-A*0201 MHC class I-restricted HPV6 E7-specific cytotoxic T lymphocyte epitopesShiwen Peng, Austin Mattox, Simon R Best, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1989
Immunohistochemical phenotyping of human solid tumors with monoclonal antibodies in devising biotherapeutic strategiesS K Liao, C Meranda, B P Avner, et al.
Pageof 652